MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Organovo Holdings Cash Conversion Cycle 2011-2026 | ONVO
Annual Cash Conversion Cycle Organovo Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -82.8 K | 310 | - | - | -783 | -38.6 | 215 | -181 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 310 | -82.8 K | -13.9 K |
Quarterly Cash Conversion Cycle Organovo Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104 | 76.5 | - | -30.7 K | -22.2 K | -23.7 K | - | 803 | - | 183 | - | 26.5 | - | - | - | - | - | - | - | - | - | - | - | -2.07 K | 200 | 10.5 | 192 | 511 | 628 | 541 | 84.9 | 160 | 75.2 | -40.6 | 94.2 | -44.5 | -2.9 | -24.6 | 21.7 | 53.7 | 20.7 | 15.2 | - | 9.85 | 29.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 803 | -30.7 K | -2.58 K |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
149 | $ 23.45 | 0.63 % | $ 252 M |  China |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
Co-Diagnostics
CODX
|
299 | $ 5.98 | -3.39 % | $ 175 M | USA |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
Castle Biosciences
CSTL
|
45.9 | $ 39.66 | 0.81 % | $ 1.1 B | USA |
 |
DexCom
DXCM
|
133 | $ 70.98 | 5.31 % | $ 27.4 B | USA |
 |
BioNano Genomics
BNGO
|
225 | $ 1.59 | 0.63 % | $ 2.02 M | USA |
 |
Guardant Health
GH
|
49.1 | $ 107.57 | -2.36 % | $ 13.2 B | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
Illumina
ILMN
|
142 | $ 145.55 | 3.18 % | $ 23.1 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 240.86 | -0.66 % | $ 43.7 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 20.57 | 20.08 % | $ 1.11 B | USA |
 |
Danaher Corporation
DHR
|
83.5 | $ 239.0 | 0.27 % | $ 175 B | USA |
 |
DarioHealth Corp.
DRIO
|
207 | $ 11.67 | -4.03 % | $ 331 M |  Israel |
 |
Anixa Biosciences
ANIX
|
275 | $ 3.16 | -6.51 % | $ 103 K | USA |
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
90.9 | $ 67.48 | -0.12 % | $ 4.67 B | USA |
 |
Exact Sciences Corporation
EXAS
|
130 | $ 102.23 | 0.12 % | $ 18.9 B | USA |
 |
Medpace Holdings
MEDP
|
51.5 | $ 599.21 | 0.71 % | $ 18.5 B | USA |
 |
Fulgent Genetics
FLGT
|
42.4 | $ 28.16 | 1.11 % | $ 851 M | USA |
 |
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | Israel |
 |
Myriad Genetics
MYGN
|
45.1 | $ 6.57 | -0.15 % | $ 595 M | USA |
 |
National Research Corporation
NRC
|
33 | $ 20.43 | 3.6 % | $ 501 M | USA |
 |
Natera
NTRA
|
81.5 | $ 235.45 | 0.49 % | $ 23.2 B | USA |
 |
OPKO Health
OPK
|
242 | $ 1.33 | -2.21 % | $ 923 M | USA |
 |
Pacific Biosciences of California
PACB
|
149 | $ 2.01 | 3.61 % | $ 510 M | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 218.82 | -0.95 % | $ 11.2 B | USA |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
Personalis
PSNL
|
-11.5 | $ 8.57 | 5.8 % | $ 508 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Mettler-Toledo International
MTD
|
63.7 | $ 1 491.99 | 0.46 % | $ 31.7 B |  Schweiz |
 |
ENDRA Life Sciences
NDRA
|
-1.24 K | $ 4.53 | -2.58 % | $ 2.43 M | USA |
 |
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | USA |
 |
Neogen Corporation
NEOG
|
150 | $ 9.37 | -2.6 % | $ 2.03 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
38.6 | $ 175.94 | 0.85 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 8.08 | 47.99 % | $ 1.05 B | USA |